Incyte (INCY) Consolidated Net Income (2009 - 2026)
Incyte (INCY) reported Consolidated Net Income of -$784.8 million for Q3 2026, compared with $424.17 million a year earlier.
Powered by 
Analysis
Incyte (INCY) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Consolidated Net Income came in at $403.41 million, down 66.1% year-over-year; for FY2025, it came in at $1.29 billion.
- By year, Consolidated Net Income came in at $32.62 million in FY2024 (-94.5%), $597.6 million in FY2023 (+75.4%), $340.66 million in FY2022 (-64.1%) and $948.58 million in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Consolidated Net Income in data going back to Q1 2010.
- Year over year, Consolidated Net Income gained in five of the last six quarters, with growth averaging 79.5%.
- The high point for year-over-year Consolidated Net Income in five years was Q1 2024 (growth of 681.2%); the low point was Q4 2022 (a decline of 95.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $585.61 million (Q2 2026), $303.33 million (Q1 2026) and $299.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -784.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -784.80 Mn |
| Jun 30, 2026 | 585.61 Mn |
| Mar 31, 2026 | 303.33 Mn |
| Dec 31, 2025 | 299.28 Mn |
| Sep 30, 2025 | 424.17 Mn |
| Jun 30, 2025 | 405.00 Mn |
| Mar 31, 2025 | 158.20 Mn |
| Dec 31, 2024 | 201.21 Mn |
| Sep 30, 2024 | 106.46 Mn |
| Jun 30, 2024 | -444.60 Mn |
| Mar 31, 2024 | 169.55 Mn |
| Dec 31, 2023 | 201.08 Mn |
| Sep 30, 2023 | 171.27 Mn |
| Jun 30, 2023 | 203.55 Mn |
| Mar 31, 2023 | 21.70 Mn |
| Dec 31, 2022 | 28.46 Mn |
| Sep 30, 2022 | 112.78 Mn |
| Jun 30, 2022 | 161.43 Mn |
| Mar 31, 2022 | 37.99 Mn |
| Dec 31, 2021 | 563.86 Mn |
API Access
Incyte Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();